BRAIN Biotech Balance Sheet Health
Financial Health criteria checks 6/6
BRAIN Biotech has a total shareholder equity of €32.7M and total debt of €0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are €77.9M and €45.2M respectively.
Key information
0%
Debt to equity ratio
€0
Debt
| Interest coverage ratio | n/a |
| Cash | €13.31m |
| Equity | €32.68m |
| Total liabilities | €45.22m |
| Total assets | €77.90m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BNND's short term assets (€31.5M) exceed its short term liabilities (€17.0M).
Long Term Liabilities: BNND's short term assets (€31.5M) exceed its long term liabilities (€28.2M).
Debt to Equity History and Analysis
Debt Level: BNND is debt free.
Reducing Debt: BNND had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BNND has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: BNND has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 7.3% each year